Nitazoxanide CAS 55981-09-4 Raw Materials Powder

CAS: 55981-09-4

MF: C12H9N3O5S

MW: 307.28

EINECS: 259-931-8

Specification​: 99% min Nitazoxanide 

Sample: Nitazoxanide Powder

Brand: Henrikang

Appearance: White Powder

Storage: Cool Dry Place

Shelf Life: 2 Years

Test Method: HPLC

Portal:https://henrikang.en.made-in-china.com/

Nitazoxanide Powder Usage and Synthesis.

Nitazoxanide Powder is widely regarded as a highly effective, broad-spectrum drug against parasitic, bacterial and fungal infections in animals and humans, and it is the first and only drug approved by the U.S. Drug and Food Administration (FDA) for the treatment of Cryptosporidium spp. Nitazoxanide Powder is widely regarded as a highly effective, broad-spectrum drug against parasitic, bacterial and fungal infections in animals and humans, and it is the first and only drug approved by the U.S. Drug and Food Administration (FDA) for the treatment of Cryptosporidium spp. 

Nitazoxanide CAS 55981-09-4 has broad-spectrum antibacterial and anti Nitazoxanide CAS 55981-09-4 has broad-spectrum antibacterial and antiparasitic effects for the treatment of Cryptosporidium spp. CAS 55981-09-4 has broad-spectrum antibacterial and antiparasitic effects for the treatment of infections caused by helminths and protozoa such as Amoeba dysenteriae, Giardia lamblia. 

Trichomonas vaginalis, and bacteria such as Campylobacter jejuni, Clostridium difficile, Clostridium perfringens, and Helicobacter pylori. The effect is similar to that of albendazole and praziquantel.

Application/Function of Nitazoxanide Powder.

Nitazoxanide is the name of a western drug. It is commonly used in the form of tablets and solutions. It is an anti-protozoal drug. It is used for the treatment of diarrhea caused by Cryptosporidium, Giardia and Amoeba; and Cryptosporidiosis in AIDS patients.

In vitro studies have shown that Nitazoxanide Powder has broad-spectrum antibacterial and antiparasitic effects for the treatment of infections caused by helminths and protozoa such as Amoeba dysenteriae, Giardia lamblia, Trichomonas vaginalis, and bacteria such as Campylobacter jejuni, Clostridium difficile, Clostridium perfringens, and Helicobacter pylori.

Nitazoxanide Raw Materials for the treatment of ascariasis and membranous cestode disease in children can provide similar effects as albendazole and praziquantel.

• 1、Treatment of diarrhea caused by Cryptosporidium, Giardia, and Amoeba protozoa.
• 2、Treatment of cryptosporidiosis associated with AIDS patients.

Nitazoxanide has the effect of inhibiting and reducing the hepatitis B virus, which can remove the hepatitis B virus present in the body of hepatitis B patients, and also has the effect of antibacterial and antiviral. Major triple yang belongs to hepatitis B major triple yang, which is a liver disease that causes serious damage to the liver and leads to liver cell necrosis. Patients taking nitazoxanide can clear the virus from the body and help a lot to cure the patient, as major triple yang is highly infectious and has active virus replication, there is no complete cure yet.

Nitazoxanide is an amide antiparasitic drug that can be used to treat symptoms such as abdominal pain and diarrhea caused by Cryptosporidium and Giardia lamblia infections. Scientific studies have also shown that it has a therapeutic effect on hepatitis B and C, as well as dysentery, diarrhea and other gastrointestinal viral infections, but in has not been conclusively proven in large-scale clinical practice, and the specific effects remain to be proven.

For patients with hepatitis B, the main treatment drugs are antiviral and hepatoprotective therapy, commonly used antiviral drugs such as interferon, entecavir, tenofovir, etc., and hepatoprotective drugs such as glycopyrrolate diamine, dicyclomine, polyphosphocholine, etc.

Production Method of Nitazoxanide Powder

1. This product is a derivative of nitazoxanide, whose structure is similar to that of aspirin. Its anti-protozoal activity is related to the interference of pyruvate-iron redox protease-dependent electron transfer reaction.

2. Studies have shown that this product is active in vivo and in vitro, and its antibacterial activity against anaerobic bacteria and Helicobacter pylori is stronger than that of metronidazole.